MediciNova Collaborates With Australia On Ibudilast Trial
This article was originally published in PharmAsia News
Executive Summary
Tokyo's MediciNova will collaborate with Australia's University of Adelaide during a Phase II trial for ibudilast for medication overuse for headaches.